Abstract
The in vivo efficacy of trovafloxacin, intraperitoneally administered as alatrofloxacin (CP-116,517), was assessed and compared with that of erythromycin, alone or in combination with rifampicin, in a model ofLegionella pneumophila pneumonia in guinea pigs. Trovafloxacin (5 mg/kg administered as alatrofloxacin once daily for 7 days) gave a survival rate of 100% in infected animals. Clearance of bacteria and of bacteria-induced lesions from lungs was achieved by day 6 post-inoculation. The lungs of trovafloxacin-treated animals remained free of bacteria at day 28 post-challenge. Trovafloxacin proved as effective as erythromycin administered intraperitoneally, but was superior to erythromycin alone, or in combination with rifampicin, when given orally.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Meyer RD: Role of the quinolones In the treatment of legionellosis. Journal of Antimicrobial Chemotherapy (1991) 28:623–625
Fitzgeorge RB, Lever S, Baskerville A: A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease. Journal of Antimicrobial Chemotherapy (1993) 31, Supplement E: 171–176
Edelstein PH: Antimicrobial chemotherapy for Legionnaires disease: a review. Clinical Infectious Diseases (1995) 21, Supplement 3:265–276
Briggs-Gooding B, Jones RN: In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrobial Agents and Chemotherapy (1993) 37:366–370
Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE: Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. Journal of Antimicrobial Chemotherapy (1995) 36:385–394
Teng R, Liston TE, Harris SC: Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers. Journal of Antimicrobial Chemotherapy (1996) 7:955–963
Andrews JM, Honeybourne D, Brenwald NP, Bannerjee D, Iredale M, Cunningham D, Wise R: Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy (1997) 39, Supplement B:797–802
Fernandes PB, Bailer R, Swanson R: In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrobial Agents and Chemotherapy (1986) 30:865–873
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M-A2. NCCLS, Villanova, PA (1994)
Saito A, Koga H, Shigeno H, Watanabe K, Mori K, Kohno S: The antimicrobial activity of ciprofloxacin againstLegionella species and the treatment of experimentalLegionella pneumonia in guinea pigs. Journal of Antimicrobial Chemotherapy (1986) 18:251–260
Fitzgeorge RB, Featherstone ASR, Baskerville A: Efficacy of azithromycin in the treatment of guinea pigs infected withLegionella pneumophila by aerosol. Journal of Antimicrobial Chemotherapy (1990) 25, Supplement A: 101–108
Edelstein PH, Edelstein MAC, Ren J, Polzer R, Gladue RP: Activity of trovafloxacin (CP-99,219) againstLegionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs withLegionella pneumophila pneumonia. Antimicrobial Agents and Chemotherapy (1996) 40:314–319
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
García-de-Lomas, J., Millás, E., Lázaro, M.A. et al. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental Legionellosis in guinea pigs. Eur. J. Clin. Microbiol. Infect. Dis. 17, 420–423 (1998). https://doi.org/10.1007/BF01691575
Issue Date:
DOI: https://doi.org/10.1007/BF01691575